ALPHARETTA, Ga., March 25, 2026 /PRNewswire/ -- Acella Pharmaceuticals, manufacturer of NP Thyroid® (Thyroid Tablets, USP), applauds the recent notice from the U.S. Food and Drug Administration (FDA) ...
As the pharmaceutical supply chain has grown more geographically diverse, drugmakers have leaned more and more on contract manufacturers to help carry the load. But bringing on a production partner ...
WASHINGTON, D.C. – Two different doses of a thyroid medication are being recalled because they're not potent enough. The Food and Drug Administration announced Thursday that Acella Pharmaceuticals is ...
People taking thyroid medications from Acella Pharmaceuticals have been warned that the company has recalled 35 commercial lots of its tablets for a lack of potency, according to the United Stated ...
Acella Pharmaceuticals is recalling 38 lots of its thyroid drug after routine testing conducted by the drugmaker found the drug to be subpotent. The recalled lots contain less than 90% of the labeled ...
Acella Pharmaceuticals can’t seem to get its thyroid medicine right. Acella recalled a whopping 35 commercial lots and three sample lots of NP Thyroid medicine, used to treat underactive thyroids, for ...
Acella Pharmaceuticals is recalling two lots of its thyroid drugs due to subpotency, the Alpharetta, Ga.-based drugmaker said Sept. 17. The drug may contain as little as 87 percent of the amount of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results